Ann Dermatol.
2023 Oct;35(5):374-388. 10.5021/ad.22.038.
Hospital Utilization and Medication Prescriptions among Patients with Atopic Dermatitis in South Korea: A Real-World Data Analysis
- Affiliations
-
- 1Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 2Department of Biomedicine & Health Sciences, The Catholic University of Korea, Seoul, Korea
- 3School of Pharmacy, Sungkyunkwan University, Suwon, Korea
- 4Pfizer Pharmaceuticals Korea Ltd., Seoul, Korea
- 5Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea
- 6Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Korea
- 7Department of Dermatology, Korea University College of Medicine, Seoul, Korea
- KMID: 2546616
- DOI: http://doi.org/10.5021/ad.22.038
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Efficacy and Safety of Dupilumab for the Treatment of Moderate to Severe Atopic Dermatitis in Korea: A Real-World Data in a Single Medical Center
- Measurement of Atopic Dermatitis Disability
- Update on management of pediatric atopic dermatitis
- Serum IgE Level in Patients of Atopic Dermatitis and Atopic Dermatitis with Molluscum Contagiosum
- Comparison of Recent Trends in Study Design and Data Analysis Guidelines Using Real-World Data/Real-World Evidence in the United States, Europe, and South Korea and Implication of Development Direction in Future
